Bruce Peacock

During his more than 35 year career in biotechnology, Bruce Peacock has held numerous senior leadership positions, including President and Chief Executive Officer of Adolor Corporation, Alba Therapeutics and Orthovita, Inc., and Chief Financial Officer (CFO) and Business Officer of Ophthotech. For over 10 years, he served as Venture Partner with SV Life Sciences Health Investors. Previously, he was Executive Vice President and Chief Operating Officer of Cephalon Inc. and prior to this, he was CFO at Centocor, Inc. He is a member of the Board of Directors of Ocular Therapeutics, PanOptica and Windtree Therapeutics. Bruce is committed to nurturing young biotechnology companies in Philadelphia: he was instrumental in the growth of Carisma Therapeutics, focused on novel cell therapies for cancer, and of Aro BioTherapeutics, developing targeted genetic medicines. Bruce holds a BA in Business Administration from Villanova University.